Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aducanumab—Hope or Disappointment for Alzheimer’s Disease
Karolina Wojtunik‐Kulesza, Monika Rudkowska, Anna Orzeł-Sajdłowska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4367-4367
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Osteocyte-derived sclerostin impairs cognitive function during ageing and Alzheimer’s disease progression
Tianshu Shi, Siyu Shen, Yong Shi, et al.
Nature Metabolism (2024) Vol. 6, Iss. 3, pp. 531-549
Closed Access | Times Cited: 27
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18
Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Ernesto Fedele
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14499-14499
Open Access | Times Cited: 33
Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management
Sayali Dighe, Sunil Jog, Munira Momin, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 58-58
Open Access | Times Cited: 24
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 14
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 10
Unraveling Alzheimer’s: the promise of aducanumab, lecanemab, and donanemab
Taha Basit Ameen, Syeda Naveera Kashif, Syed Muhammad Iraj Abbas, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access | Times Cited: 9
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Devika Jadhav, Nikita Saraswat, Neeraj S. Vyawahare, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access | Times Cited: 8
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target
Rubén López-Hernández, María Magdalena de la Torre-Álamo, Borja García‐Bueno, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 121-121
Open Access | Times Cited: 1
Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment
Mariagiovanna Cozza, Lucia Amadori, Virginia Boccardi
Journal of the Neurological Sciences (2023) Vol. 454, pp. 120866-120866
Open Access | Times Cited: 17
Alzheimer’s Disease Immunotherapy: Current Strategies and Future Prospects
Ali Aljassabi, Tarek Zieneldien, Janice Kim, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 3, pp. 755-772
Closed Access | Times Cited: 6
Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
Yanxin Shen, Meng Zhao, Panpan Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond
Giacomo Tondo, Fabiola De Marchi, Francesca Bonardi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3098-3098
Open Access | Times Cited: 5
Osteoporosis and Alzheimer´s disease (or Alzheimer´s disease and Osteoporosis)
Nahuel Ezequiel Wanionok, Gustavo R Morel, Juan Manuel Fernández
Ageing Research Reviews (2024) Vol. 99, pp. 102408-102408
Closed Access | Times Cited: 5
SERCA pump as a novel therapeutic target for treating neurodegenerative disorders
Russell Dahl, Ilya Bezprozvanny
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150748-150748
Closed Access | Times Cited: 5
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 5
Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease
Ides M. Colin, Lidia W Szczepanski, A Gérard, et al.
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 16-16
Open Access | Times Cited: 11
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease
Nicholas Aderinto, Israel Charles Abraham, Gbolahan Olatunji, et al.
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
Nanoscale drug formulations for the treatment of Alzheimer's disease progression
Liu Liqin, Haini He, Bert N. La Du, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4031-4078
Open Access
Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease
Milan Fiala, Bruce D. Hammock, Sung Hee Hwang, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Intranasal Delivery of Lithium Salt Suppresses Inflammatory Pyroptosis in the Brain and Ameliorates Memory Loss and Depression-like Behavior in 5XFAD Mice
Piplu Bhuiyan, Wenjia Zhang, Liang Ge, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access
Melatonin regulation of phase separation in Neuro-PASC: out-maneuvering Janus-faced amyloids
Doris Loh, Russel J. Reıter
Exploration of neuroscience (2025) Vol. 4
Open Access
Protein aggregation and biomolecular condensation in hypoxic environments (Review)
Chaoqun Li, Bingjie Hao, Haiguang Yang, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 4
Open Access | Times Cited: 3
Profiling aducanumab as a treatment option for alzheimer’s disease: an overview of efficacy, safety and tolerability
Shreeya Thussu, Aniketh Naidu, Sindhu Manivannan, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-9
Closed Access | Times Cited: 3
Positive Allosteric Modulators of SERCA Pump Restore Dendritic Spines and Rescue Long-Term Potentiation Defects in Alzheimer’s Disease Mouse Model
Anastasiya Rakovskaya, Alexander Erofeev, E. K. Vinokurov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13973-13973
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top